Xiaopeng Ai
Impact in
- Biochemistry top 5%
- Phytochemicals and Antioxidant Activities
Papers in
-
- Gut microbiota and health 2
- Natural product bioactivities and synthesis 2
-
- Berberine and alkaloids research 3
- Co-authors
- Xianli Meng (12 shared papers)Ya Hou (11 shared papers)Xiaobo Wang (10 shared papers)Xiaorui Chen (2 shared papers)Jinrong Bai (4 shared papers)Ce Tang (1 shared paper)Yi Zhang (1 shared paper)Yunsen Zhang (1 shared paper)
- Journals
- Journal of Ethnopharmacology (6 papers)International Journal of Biological Macromolecules (4 papers)Biomedicine & Pharmacotherapy (3 papers)Scientific Reports (2 papers)Reviews in the Neurosciences (1 paper)
- Partner nations
- ChinaSouth Korea
In The Last Decade
Xiaopeng Ai
23 papers receiving 1.2k citations
Xiaopeng Ai's Hit Papers
Peers
Comparison fields: 5 of 118
- Applied Microbiology and Biotechnology 36
- Biochemistry 95
- Pharmacology 111
- Complementary and alternative medicine 90
- Pharmacology 140
Countries citing papers authored by Xiaopeng Ai
This map shows the geographic impact of Xiaopeng Ai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaopeng Ai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaopeng Ai more than expected).
Fields of papers citing papers by Xiaopeng Ai
This network shows the impact of papers produced by Xiaopeng Ai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaopeng Ai. The network helps show where Xiaopeng Ai may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaopeng Ai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gallic acid: Pharmacological activities and molecular mechanisms involved in inflammation-related diseases Hit paper breakdown → | 2020 | 510 |
| 2 | 2021 | 126 | |
| 3 | 2019 | 81 | |
| 4 | 2023 | 65 | |
| 5 | 2020 | 53 | |
| 6 | 2024 | 49 | |
| 7 | 2020 | 47 | |
| 8 | 2020 | 45 | |
| 9 | 2022 | 43 | |
| 10 | 2019 | 41 | |
| 11 | 2024 | 26 | |
| 12 | 2018 | 22 | |
| 13 | 2020 | 22 | |
| 14 | 2019 | 21 | |
| 15 | 2024 | 15 | |
| 16 | 2021 | 13 | |
| 17 | 2021 | 8 | |
| 18 | 2025 | 8 | |
| 19 | 2018 | 7 | |
| 20 | 2025 | 7 |
About Xiaopeng Ai
Xiaopeng Ai is a scholar working on Molecular Biology, Pharmacology, Pharmacology, Plant Science and Infectious Diseases, having authored 25 papers that have together received 1.2k indexed citations. Recurring topics across this work include Polysaccharides and Plant Cell Walls (3 papers), Berberine and alkaloids research (3 papers), High Altitude and Hypoxia (2 papers), Chronic Kidney Disease and Diabetes (2 papers), Gastrointestinal motility and disorders (2 papers), Gut microbiota and health (2 papers), Clostridium difficile and Clostridium perfringens research (2 papers) and Natural product bioactivities and synthesis (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (36 citations), Biochemistry (95 citations), Pharmacology (111 citations), Complementary and alternative medicine (90 citations) and Pharmacology (140 citations). Xiaopeng Ai has collaborated with scholars based in China and South Korea. Frequent co-authors include Xianli Meng, Ya Hou, Xiaobo Wang, Xiaorui Chen, Jinrong Bai, Ce Tang, Yi Zhang, Yunsen Zhang, Peiling Yu and Xianrong Lai. Their work appears in journals such as Journal of Ethnopharmacology, International Journal of Biological Macromolecules, Biomedicine & Pharmacotherapy, Scientific Reports and Reviews in the Neurosciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.